614 related articles for article (PubMed ID: 16741643)
21. Relationship between plasma levels of vascular endothelial growth factor and serum levels of interleukin-12 in patients with colorectal cancer.
Nakayama Y; Sako T; Shibao K; Onitsuka K; Nagashima N; Hirata K; Nagata N; Itoh H
Anticancer Res; 2000; 20(6A):4097-102. PubMed ID: 11131678
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor (VEGF)--a valuable serum tumour marker in patients with colorectal cancer?
Broll R; Erdmann H; Duchrow M; Oevermann E; Schwandner O; Markert U; Bruch HP; Windhövel U
Eur J Surg Oncol; 2001 Feb; 27(1):37-42. PubMed ID: 11237490
[TBL] [Abstract][Full Text] [Related]
23. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
[TBL] [Abstract][Full Text] [Related]
25. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC
J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244
[TBL] [Abstract][Full Text] [Related]
26. Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer.
Chin KF; Greenman J; Gardiner E; Kumar H; Topping K; Monson J
Br J Cancer; 2000 Dec; 83(11):1425-31. PubMed ID: 11076648
[TBL] [Abstract][Full Text] [Related]
27. Use of the preoperative levels of CEA in patients with colorectal cancer.
Marchena J; Acosta MA; Garcia-Anguiano F; Simpson H; Cruz F
Hepatogastroenterology; 2003; 50(52):1017-20. PubMed ID: 12845969
[TBL] [Abstract][Full Text] [Related]
28. Colorectal resection is associated with persistent proangiogenic plasma protein changes: postoperative plasma stimulates in vitro endothelial cell growth, migration, and invasion.
Kumara HM; Feingold D; Kalady M; Dujovny N; Senagore A; Hyman N; Cekic V; Whelan RL
Ann Surg; 2009 Jun; 249(6):973-7. PubMed ID: 19474682
[TBL] [Abstract][Full Text] [Related]
29. [Carcinoembryonic antigen in diagnosis and monitoring of colorectal cancer].
Forones NM; Tanaka M; Machado D; Falcão JB; Giovanoni M
Arq Gastroenterol; 1997; 34(1):3-6. PubMed ID: 9458953
[TBL] [Abstract][Full Text] [Related]
30. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma.
Mitsuhashi A; Suzuka K; Yamazawa K; Matsui H; Seki K; Sekiya S
Cancer; 2005 Feb; 103(4):724-30. PubMed ID: 15637689
[TBL] [Abstract][Full Text] [Related]
31. Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer.
George DJ; Regan MM; Oh WK; Tay MH; Manola J; Decalo N; Duggan S; Dewolf WC; Kantoff PW; Bubley GJ
Urology; 2004 Feb; 63(2):327-32. PubMed ID: 14972483
[TBL] [Abstract][Full Text] [Related]
32. Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis.
Soumaoro LT; Uetake H; Takagi Y; Iida S; Higuchi T; Yasuno M; Enomoto M; Sugihara K
Dis Colon Rectum; 2006 Mar; 49(3):392-8. PubMed ID: 16474989
[TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor and psychosocial factors in colorectal cancer.
Sharma A; Greenman J; Sharp DM; Walker LG; Monson JR
Psychooncology; 2008 Jan; 17(1):66-73. PubMed ID: 17410522
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
35. Comparison of angiogenic factor levels in tumor drainage and peripheral venous blood from colorectal cancer patients.
Tien YW; Chang KJ; Chiu YF; Huang KW; Lee PH
Ann Surg Oncol; 2006 Nov; 13(11):1357-63. PubMed ID: 17001510
[TBL] [Abstract][Full Text] [Related]
36. Soluble intercellular adhesion molecule-1 as a prognostic marker for stage II colorectal cancer patients.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Koike Y; Yokoe T; Tanaka K; Kusunoki M
Ann Surg Oncol; 2008 Jun; 15(6):1617-24. PubMed ID: 18368454
[TBL] [Abstract][Full Text] [Related]
37. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
Chen C; Chen LQ; Yang GL; Li Y
Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
[TBL] [Abstract][Full Text] [Related]
38. Can preoperative and postoperative CEA predict survival after colon cancer resection?
Slentz K; Senagore A; Hibbert J; Mazier WP; Talbott TM
Am Surg; 1994 Jul; 60(7):528-31; discussion 531-2. PubMed ID: 8010568
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of plasma D-dimer levels and serum VEGF levels in patients with hepatocellular carcinoma.
Tseng CS; Lo HW; Chen PH; Chuang WL; Juan CC; Ker CG
Hepatogastroenterology; 2004; 51(59):1454-8. PubMed ID: 15362775
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor concentrations in the plasma-activated platelets rich (P-APR) of healthy controls and colorectal cancer patients.
Ranieri G; Coviello M; Patruno R; Valerio P; Martino D; Milella P; Catalano V; Scotto F; De Ceglie A; Quaranta M; Ribatti D; Pellecchia A
Oncol Rep; 2004 Oct; 12(4):817-20. PubMed ID: 15375505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
